News
Evosep, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform ...
Mursla Bio introduces AI Precision Medicine Platform built on organ-specific EV isolation from blood
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly ...
Lead author Claire Morton, MD, and senior author Christina Ahn Minami, MD, MS, both of the Department of Surgery at Brigham ...
Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today ...
A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that ...
What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter ...
Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other ...
Six out of ten people with type 2 diabetes had fatty liver in a new study from . Of these, only a small percentage had ...
Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.
Earlier this month, the most recent team-building event saw the Bedfont ® office close for the afternoon, and staff were ...
A new grant from the National Institutes of Health (NIH) will help Wayne State University researchers explore potential ...
Nearly two-thirds of adults oppose President Donald Trump's "One Big Beautiful Bill" approved in May by the House of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results